MALARONE - 55289-747-20 - (atovaquone and proguanil hydrochloride)

Alphabetical Index


Drug Information of MALARONE

Product NDC: 55289-747
Proprietary Name: MALARONE
Non Proprietary Name: atovaquone and proguanil hydrochloride
Active Ingredient(s): 250; 100    mg/1; mg/1 & nbsp;   atovaquone and proguanil hydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of MALARONE

Product NDC: 55289-747
Labeler Name: PD-Rx Pharmaceuticals, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA021078
Marketing Category: NDA
Start Marketing Date: 20000726

Package Information of MALARONE

Package NDC: 55289-747-20
Package Description: 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-747-20)

NDC Information of MALARONE

NDC Code 55289-747-20
Proprietary Name MALARONE
Package Description 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-747-20)
Product NDC 55289-747
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name atovaquone and proguanil hydrochloride
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20000726
Marketing Category Name NDA
Labeler Name PD-Rx Pharmaceuticals, Inc.
Substance Name ATOVAQUONE; PROGUANIL HYDROCHLORIDE
Strength Number 250; 100
Strength Unit mg/1; mg/1
Pharmaceutical Classes Antimalarial [EPC],Antiprotozoal [EPC],Antimalarial [EPC],Dihydrofolate Reductase Inhibitors [MoA]

Complete Information of MALARONE


General Information